Progress in spinal cord organoid research: advancing understanding of neural development, disease modelling, and regenerative medicine.

Biomaterials Translational Pub Date : 2024-11-15 eCollection Date: 2024-01-01 DOI:10.12336/biomatertransl.2024.04.003

Ruiqi Huang, Yanjing Zhu, Haokun Chen, Liqun Yu, Zhibo Liu, Yuchen Liu, Zhaojie Wang, Xiaolie He, Li Yang, Xu Xu, Yuxin Bai, Bairu Chen, Rongrong Zhu

{"title":"Progress in spinal cord organoid research: advancing understanding of neural development, disease modelling, and regenerative medicine.","authors":"Ruiqi Huang, Yanjing Zhu, Haokun Chen, Liqun Yu, Zhibo Liu, Yuchen Liu, Zhaojie Wang, Xiaolie He, Li Yang, Xu Xu, Yuxin Bai, Bairu Chen, Rongrong Zhu","doi":"10.12336/biomatertransl.2024.04.003","DOIUrl":null,"url":null,"abstract":"<p><p>Stem cell-derived spinal cord organoids (SCOs) have revolutionised the study of spinal cord development and disease mechanisms, offering a three-dimensional model that recapitulates the complexity of native tissue. This review synthesises recent advancements in SCO technology, highlighting their role in modelling spinal cord morphogenesis and their application in neurodegenerative disease research. We discuss the methodological breakthroughs in inducing regional specification and cellular diversity within SCOs, which have enhanced their predictive ability for drug screening and their relevance in mimicking pathological conditions such as neurodegenerative diseases and neuromuscular disorders. Despite these strides, challenges in achieving vascularisation and mature neuronal integration persist. The future of SCOs lies in addressing these limitations, potentially leading to transformative impactions in regenerative medicine and therapeutic development.</p>","PeriodicalId":58820,"journal":{"name":"Biomaterials Translational","volume":"5 4","pages":"355-371"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11764192/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomaterials Translational","FirstCategoryId":"1087","ListUrlMain":"https://doi.org/10.12336/biomatertransl.2024.04.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Stem cell-derived spinal cord organoids (SCOs) have revolutionised the study of spinal cord development and disease mechanisms, offering a three-dimensional model that recapitulates the complexity of native tissue. This review synthesises recent advancements in SCO technology, highlighting their role in modelling spinal cord morphogenesis and their application in neurodegenerative disease research. We discuss the methodological breakthroughs in inducing regional specification and cellular diversity within SCOs, which have enhanced their predictive ability for drug screening and their relevance in mimicking pathological conditions such as neurodegenerative diseases and neuromuscular disorders. Despite these strides, challenges in achieving vascularisation and mature neuronal integration persist. The future of SCOs lies in addressing these limitations, potentially leading to transformative impactions in regenerative medicine and therapeutic development.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Biomaterials Translational

CiteScore

6.70

自引率

0.00%

发文量